These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2188039)

  • 1. [Mononuclear phagocytes and their growth factors: pacemakers of proliferative vitreoretinopathy?].
    Weller M; Heimann K; Wiedemann P
    Klin Monbl Augenheilkd; 1990 Mar; 196(3):121-7. PubMed ID: 2188039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferative vitreoretinopathy: new discoveries in pathophysiology and therapy].
    Wiedemann P; Weller M; Heimann K
    Klin Monbl Augenheilkd; 1990 Nov; 197(5):355-61. PubMed ID: 2290290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of macrophages and fibronectin in vitreoretinal proliferation].
    Weller M; Heimann K; Wiedemann P
    J Fr Ophtalmol; 1988; 11(3):243-7. PubMed ID: 3047202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental studies of proliferative vitreoretinopathy].
    Kain HL
    Fortschr Ophthalmol; 1991; 88(6):671-6. PubMed ID: 1794788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
    Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.
    Connor TB; Roberts AB; Sporn MB; Danielpour D; Dart LL; Michels RG; de Bustros S; Enger C; Kato H; Lansing M
    J Clin Invest; 1989 May; 83(5):1661-6. PubMed ID: 2708527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages.
    Diemel LT; Jackson SJ; Cuzner ML
    J Neurosci Res; 2003 Dec; 74(6):858-67. PubMed ID: 14648590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M; Esser P; Heimann K; Wiedemann P
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
    Wang F; Xu X; Zhang X; Yan Y
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.
    Ikuno Y; Leong FL; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3107-16. PubMed ID: 10967071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH; Occleston NL; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of platelet-derived growth factor B mRNA abundance in macrophages by colchicine and dibutyryl-cAMP.
    Wangoo A; Haynes AR; Sutcliffe SP; Sorooshian M; Shaw RJ
    Mol Pharmacol; 1992 Oct; 42(4):584-9. PubMed ID: 1331750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction.
    Carrington L; McLeod D; Boulton M
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1210-6. PubMed ID: 10752962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical findings in proliferative retinal diseases--on the significance of fibronectin, macrophages and transferrin].
    Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1989; 86(2):121-3. PubMed ID: 2661370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B; Sorgente N
    Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M; Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferative vitreoretinopathy. On the significance of protein transfer through the blood-retina barrier].
    Grisanti S; Wiedemann P; Heimann K
    Ophthalmologe; 1993 Oct; 90(5):468-71. PubMed ID: 8219633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.